| 摘要 |
<p>The absorption of a therapeutically active protein (I) in the blood is improved by intramuscular injection of (I) together with an absorption enhancing agent (II). Particularly, the method is used where (I) has a short in vivo half-life and allows an effective concn. to be maintained for at least 30 min. Also new are packages contg. (I) and (II).</p> |
